Dietary Glycaemic Index Labelling: A Global Perspective
Alan W Barclay1, Livia S A Augustin2, Furio Brighenti3
1Accredited Practising Dietitian, Sydney 2209, Australia.
The glycaemic index (GI), a measure of carbohydrate impact on blood glucose, lacks consistent global food labeling regulations. Harmonizing these rules would benefit consumers managing diabetes and at-risk individuals.
Area of Science:
- Food science and nutrition
- Public health policy
- Consumer protection
Background:
- The glycaemic index (GI) quantifies the acute effect of digestible carbohydrates on blood glucose levels.
- Current global food labeling regulations for GI information are inconsistent, despite its potential to aid blood glucose management.
- Consumer and health professional confidence is eroded by these regulatory discrepancies.
Purpose of the Study:
- To review and compare international regulations regarding glycaemic index (GI) claims on food labels.
- To highlight the inconsistencies in GI claim regulations across different countries and regions.
- To advocate for global harmonization of GI labeling policies.
Main Methods:
- Comparative analysis of food labeling regulations in Australia, New Zealand, South Africa, Singapore, India, China, USA, Canada, and the European Union.
- Review of existing food standard codes and voluntary labeling provisions related to GI.
- Identification of regulatory frameworks governing GI claims and endorsements.
Main Results:
- Australia, New Zealand, South Africa, Singapore, and India have specific regulations or endorsements for GI claims.
- GI claims are permitted but not specifically regulated in China and the USA.
- GI claims are not legal under current food law in Canada and the European Union.
Conclusions:
- Significant global inconsistencies exist in the regulation of glycaemic index (GI) claims on food labels.
- Harmonization of international food standards for GI claims and endorsements is necessary.
- Standardized global provisions for GI information on food labels would support individuals with diabetes and those at risk.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
13:21Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
Published on: May 4, 2012
Related Concept Videos
Protein Glycosylation
Glycosylation occurs in...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Oral Hypoglycemic Agents: Glinides
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Dietary Connections
Hypoglycemia and Glucagon
